Medicine for the Subspecialist and Primary Care Physician (PCP): Novel Therapies that are Changing Practice

Medicine for the Subspecialist and Primary Care Physician (PCP): Novel Therapies that are Changing Practice is organized by 360 Medical Education LLC and will be held from on March 9 and 10, 2022 from 8:00 PM to 9:00 PM ET / 5:00 PM - 6:00 PM PT. 

Target Audience:
Join us for our FREE, two-night interactive virtual conference specifically designed for Primary Care Physicians, where we will cover new treatments for common conditions.

Description:
Learn practical tips and pearls from our expert faculty that you can apply to your everyday practice! This FREE CME course will provide the most current approaches to common conditions such as heart failure, hypertension, diabetes, hyperlipidemia, inflammatory bowel disease, and chronic kidney disease.  Dr. Deepak L. Bhatt and the faculty invite you to join the program over two very informative evenings from the comfort of your home with this exciting webinar series held over 2 evenings. Each presentation will feature a review of the latest information providers need to know in their every day practice followed by engaging panel discussions and audience question and answer sessions.

The Medicine for the Subspecialist and PCP program includes educational seminars that provides primary healthcare professionals with access to highly practical clinical education to improve their practice and patient outcomes. Program attendees will learn directly from world-renowned physicians and experts who will share information on best practices across multiple specialties. Programs are designed for education to be consumed in a highly digestible form so attendees will get the practice tips and pearls to immediately apply to their practice.

Conditions Include:
• Heart failure
• Hypertension
• Diabetes
• Hyperlipidemia
• Inflammatory bowel disease
• Chronic kidney disease
• Dermatology for primary care

Learning Objectives:
After participating in this activity, participants will be better able to: 
• Provide optimal care in the most common and prevalent disease states in accordance with newly updated clinical practice guidelines
• Assess new and emerging clinical therapies for heart failure, resistant hypertension, chronic kidney disease, dyslipidemia, diabetes, inflammatory bowel disease, dermatology, and COVID-19
• List ongoing recent and ongoing trials in these areas
• Discuss the impact on clinical practice of all the new data